Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview
Ganji Purnachandra Nagaraju, Batoul Farran, Tha Luong, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 67-80
Open Access | Times Cited: 19

Showing 19 citing articles:

Role of STAT3 in pancreatic cancer
Zachary Hamel, S. Calabrese Sánchez, David Standing, et al.
Exploration of Targeted Anti-tumor Therapy (2024) Vol. 5, Iss. 1, pp. 20-33
Open Access | Times Cited: 8
An Ellagic Acid Coordinated Copper‐Based Nanoplatform for Efficiently Overcoming Cancer Chemoresistance by Cuproptosis and Synergistic Inhibition of Cancer Cell Stemness
Shuaijun Lu, Hailong Tian, Bowen Li, et al.
Small (2023) Vol. 20, Iss. 17
Open Access | Times Cited: 16
OTU deubiquitinase, ubiquitin aldehyde binding 2 (OTUB2) modulates the stemness feature, chemoresistance, and epithelial-mesenchymal transition of colon cancer via regulating GINS complex subunit 1 (GINS1) expression
Wenjie Zhu, Changlei Wu, Zitao Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
FOXM1-Driven CKS1B Upregulation Promotes Pancreatic Cancer Progression and Therapeutic Resistance
Li Zhang, Fang Wei, Qihui Sun, et al.
International Journal of Biological Sciences (2025) Vol. 21, Iss. 3, pp. 1047-1064
Open Access
Functional Characterization of miR-216a-5p and miR-125a-5p on Pancreatic Cancer Stem Cells
Grazia Fenu, Carmen Griñán‐Lisón, Federica Etzi, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 2830-2830
Open Access
Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell
Diana Tavares‐Valente, Stefania Cannone, Maria Raffaella Greco, et al.
Cancers (2023) Vol. 15, Iss. 15, pp. 3868-3868
Open Access | Times Cited: 5
Pathological Nodal and Vascular Involvement Significantly Impacts the Recurrence Risk in Different Time Frames in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Hidenori Takahashi, Hirofumi Akita, Hiroshi Wada, et al.
Annals of Surgery (2023) Vol. 278, Iss. 6, pp. e1216-e1223
Closed Access | Times Cited: 4
Machine Learning Developed a MYC Expression Feature-Based Signature for Predicting Prognosis and Chemoresistance in Pancreatic Adenocarcinoma
Biao Dong, Yueshan Zhang, Han Gao, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 1
CircMALAT1 promotes cancer stem‐like properties and chemoresistance via regulating Musashi‐2/c‐Myc axis in esophageal squamous cell carcinoma
Zitong Zhao, Yingni Deng, Jing Han, et al.
MedComm (2024) Vol. 5, Iss. 6
Open Access | Times Cited: 1
Unveiling the Resistance to Therapies in Pancreatic Ductal Adenocarcinoma
Ashu Shah, Koelina Ganguly, Sanchita Rauth, et al.
Drug Resistance Updates (2024) Vol. 77, pp. 101146-101146
Closed Access | Times Cited: 1
B3GNT5 is a novel marker correlated with malignant phenotype and poor outcome in pancreatic cancer
Wei Yao, Yihui Wang, Xin Zhang, et al.
iScience (2024) Vol. 27, Iss. 10, pp. 110889-110889
Open Access | Times Cited: 1
Unveiling the microRNA landscape in pancreatic ductal adenocarcinoma patients and cancer cell models
Grazia Fenu, Carmen Griñán‐Lisón, Andrea Pisano, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
CCDC34 maintains stemness phenotype through β-catenin-mediated autophagy and promotes EGFR-TKI resistance in lung adenocarcinoma
Ping Yue, Yuchao He, Ran Zuo, et al.
Cancer Gene Therapy (2024)
Closed Access | Times Cited: 1
IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer
Xiaohui Li, G. Huang, Zi-lan Xu, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Editorial: Regulating cell cycle-related activities: The right target for cancer therapy
Hang Fai Kwok
Seminars in Cancer Biology (2024) Vol. 98, pp. 64-65
Closed Access
Isoleucyl-tRNA synthetase 2 promotes pancreatic ductal adenocarcinoma proliferation and metastasis by stabilizing β-catenin
Yixun Jin, Xinyang Huang, Zhuoxin Wang, et al.
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101382-101382
Open Access
Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β‑catenin pathway in liver cancer
Junying Wang, Guangyu Zhu
Oncology Letters (2023) Vol. 26, Iss. 4
Open Access | Times Cited: 1
A niche-mimicking polymer hydrogel-based approach to identify molecular targets for tackling human pancreatic cancer stem cells
Yoshitaka Murota, Mariko Nagane, Mei Wu, et al.
Inflammation and Regeneration (2023) Vol. 43, Iss. 1
Open Access
Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer
Dangran Li, S.-Y. Weng, Kai Zeng, et al.
Gene (2023) Vol. 895, pp. 148007-148007
Closed Access
Page 1

Scroll to top